For the first time, women in the United States have the ability to self-collect a sample to screen for human papillomavirus (HPV). This week, the U.S. Food and Drug Administration approved two ...

Doctors address the pros and cons of Health Resources and Services Administration’s new guidance, including at-home ...

Mailing at-home human papillomavirus (HPV) self-collection tests and providing booking assistance for in-clinic screening visits nearly doubled the rate of cervical cancer screenings among ...

The first at-home screening kit for human papillomavirus, the leading cause of cervical cancer in the U.S., has been approved by the U.S. Food and Drug Administration. The prescription device from ...

According to the American Cancer Society's estimates, in 2025, about 13,360 new cases of invasive cervical cancer will be diagnosed, and about 4,320 women will die from cervical cancer. Cervical ...

LONDON--(BUSINESS WIRE)--Technavio analysts forecast the global cervical cancer diagnostic testing market to grow at a CAGR of over 6% during the forecast period, according to their latest market ...